UNIVERCELLS
Hugues Bultot is a seasoned executive with extensive leadership experience in the biopharmaceutical sector. As the Chief Executive Officer and co-founder of UNIVERCELLS since January 2013, Hugues has played a pivotal role in the company's development. Previous positions include CEO roles at UNIZIMA and EXOTHERA, as well as serving on the board of directors for several companies, including MaSTherCell, Orgenesis Inc, Vivaldi Biosciences Inc., and Ovizio. Hugues co-founded KITOZYME and has held various management and advisory roles throughout the industry. Hugues' educational background features an array of esteemed institutions, including IMD, MIT Sloan School of Management, and INSEAD, among others, with degrees focusing on innovation, management, and law.
UNIVERCELLS
1 followers
Univercells is a global life sciences company making biologics available to everyone. We operate as a campus of start-ups: five businesses solving different parts of the same puzzle - meeting global demand for bioproduction. Because it is not enough for a drug to exist. To change the world it must be accessible to everyone. Each division of affiliates operates a different part of the healthcare value chain, through a distinct business model: Exothera is a Contract Manufacturing and Development Organization (CDMO) for biologicals, mainly vaccines and viral vectors, with GMP production facilities in Belgium and offering process development and optimization services. https://exothera.world/. Unizima delivers international project management of technology transfer, alongside operational support services (quality, supply chain, digital) and bioproduction training programs, as well as care centers and diagnostics surveillance centers. https://unizima.com/. At Quantoom Biosciences, scientists, engineers and clinicians are committed to solve some of the biggest challenges facing mRNA-based vaccines and therapeutics by developing an end-to-end RNA Platform. This includes DNA and RNA manufacturing and formulation, along with critical reagent supply, from sequence to large-scale production. https://www.quantoom.com/. Thanks to a substantial knowledge of the pharmaceutical industry and a strong scientific background, RLM Consulting provides international regulatory affairs support at all stages of product development, from discovery research through preclinical and clinical testing, up to and beyond submission of the dossier for marketing authorization. http://www.rlmconsulting.be/.